Next-Generation Sequencing (NGS) Services- Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Eurofins Scientific, Personalis, Natera, Illumina, Roche, BGI

Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Next-Generation Sequencing (NGS) Services Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 21.4% during the review period (2022 to 2027)

Next-Generation Sequencing (NGS) Services Market Overview:

The growth of this market is mainly attributed to the reducing cost of NGS procedures, the development, and approval of new targeted therapies, rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.

With the World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, along with major players and smaller start-ups in the NGS market, have stepped forward to contribute to worldwide research efforts of developing test kits, treatments, and vaccines. Companies have scaled up R&D efforts to develop vaccines and drugs against the virus. 

Market Growth Driver

Advancements in NGS platforms: 

Continuous technological advancements in sequencers have enabled the development of efficient, portable, and simple-to-use NGS platforms that can deliver fast and precise results while also reducing turnaround times. The introduction of such products and the technology that underpins them gives players an immediate competitive advantage; as a result, major corporations are increasingly focused on product research and development to increase their market positions and share.

Industry News and Updates:

2022/04/11: BGI Receives CE-IVDD Mark for its SARS-CoV-2 Virus Antigen Detection Kit (Colloidal Gold Method)--

BGI announces that its SARS-CoV-2 Virus Antigen Detection Kit (Colloidal Gold Method) – self-test version has obtained the European CE marking for in vitro diagnostic use (CE-IVDD).

Aug. 19, 2020-- Thermo Fisher Scientific introduces hematology-oncology portfolio for Ion Torrent Genexus System--

In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) results can be reduced to less than 24 hours.

What are the major Applications, Types and Regions for Next-Generation Sequencing (NGS) Services Market?

By Type, it is segmented into

• Targeted Sequencing


• Whole Exome Sequencing


• Whole Genome Sequencing

By Applications, it is segmented into

• Diagnostics


• Biomarkers and Cancer


• Reproductive Health


• Personalized Medicine


• Agriculture and Animal Research


• Other 

By End-User, it is segmented into

• Hospitals and Clinics


• Biopharma Companies


• Academic & Research Organizations


• Others

Market Segments Analysis

• The whole-genome sequencing segment is likely to increase significantly in the future years. Whole-genome sequencing (WGS) has gained widespread acceptance as a means of obtaining the highest possible resolution information regarding COVID-19, and it is thought to have the potential to revolutionize COVID-19 infectious disease management.


• The biomarker and cancer sector dominated the market in 2020 and is likely to continue this trend during the forecast period, owing to an increase in cancer prevalence and advancements in technology in next-generation sequencing.


• The academic & clinical research centers segment dominated the market in 2020 and is likely to continue this trend throughout the forecast period, owing to growth in application-based usage in these institutes and an increase in oncology research.

Next-Generation Sequencing (NGS) Services Market Regional Analysis

In 2020, North America will have the greatest revenue share in the worldwide market. The increasing number of patent and trademark registrations as a result of increased R&D activities and product launches, as well as the presence of key market players in the region, are key factors contributing to North America's revenue share of the global Next-Generation Sequencing (NGS) Services market. Furthermore, low patent renewal/maintenance costs imposed by the United States Patent and Trademark Office to avoid undue financial stress on patentees are a crucial element contributing to the market's revenue development. Due to increased R&D efforts and product improvements, as well as the resulting growth in patent and trademark registrations, Asia Pacific is likely to post a consistent revenue CAGR during the projection period. The availability of a comprehensive suite of IP renewal services at reasonable prices, including advice on the patentability of inventions, filing and prosecution of patent applications, and proper renewal service guidance, has increased their adoption across APAC countries and contributed to the APAC market's revenue growth.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Next-Generation Sequencing (NGS) Services Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Next-Generation Sequencing (NGS) Services Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Next-Generation Sequencing (NGS) Services Market Report Scope?

Key Takeaways from this Next-Generation Sequencing (NGS) Services Report

• Evaluate Next-Generation Sequencing (NGS) Services market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Next-Generation Sequencing (NGS) Services market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of the Next-Generation Sequencing (NGS) Services Market?

The Next-Generation Sequencing (NGS) Services Market is growing at a CAGR of 21.4% over the next 5 years.

Who are the key players in Next-Generation Sequencing (NGS) Services Market?

Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), GENEWIZ (US), Psomagen, Inc. (South Korea), 10x Genomics (US), Takara Bio (Japan), Zymo Research (US), NuGen Technologies (US), Hamilton Company (US), Beckman Coulter (US), Becton, Dickinson, and Company (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China)

What are the significant types of Next-Generation Sequencing (NGS) Services Market?

Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing

What are the major end-use applications of Next-Generation Sequencing (NGS) Services Market?

Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, Other

On the basis on application, which segment holds the major share in the Next-Generation Sequencing (NGS) Services Market?

Biomarkers and Cancer held the largest share in Next-Generation Sequencing (NGS) Services market.

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.